| Politician | Action | Description | Traded |
|---|---|---|---|
| Buy | AUTODESEK, INC. CMN | Apr 21, 2026 | |
| Sell | ARBUTUS BIOPHARMA CORPORATIO | Jun 4, 2025 |
This page tracks congressional stock trading activity in Arbutus Biopharma Corporation (ABUS) in the Healthcare sector. Disclosed Capitol has indexed 2 disclosed congressional trades involving ABUS. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of May 2026 — Disclosed Capitol has tracked 2 disclosed congressional trades in Arbutus Biopharma Corporation (ABUS) — 1 sells with no recorded buys — led by Ro Khanna (D).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| Apr 21, 2026 | Ro Khanna | D | Buy | $15,001 - $50,000 |
| Jun 4, 2025 | John W. Rose | R | Sale | $250,001 - $500,000 |
Across the 2 disclosed congressional trades in Arbutus Biopharma Corporation (ABUS), members of Congress have reported 0 buys and 1 sell. The average 30-day alpha vs. the S&P 500 is -7.75%.
For fiscal year 2025, Arbutus Biopharma Corporation reported revenue of $14.1M and net income of -$33.5M, per SEC filings.
Most recent reported quarter: Q2 FY2026 — revenue $180.1M, net income $164.6M.
Figures come from SEC financial statement filings. The full annual and quarterly statement history is in the Financials tab above.